# 18F-Fluorocholine for the Detection of Parathyroid Adenomas

> **NCT03764007** · PHASE2,PHASE3 · COMPLETED · sponsor: **Thomas Hope** · enrollment: 98 (actual)

## Conditions studied

- Hyperparathyroidism, Primary

## Interventions

- **DRUG:** 18F-Fluorocholine
- **PROCEDURE:** Positron Emission Tomography (PET)

## Key facts

- **NCT ID:** NCT03764007
- **Lead sponsor:** Thomas Hope
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-21
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-05-31
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2021-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03764007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03764007, "18F-Fluorocholine for the Detection of Parathyroid Adenomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03764007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*